Allergic rhinitis may attenuate the sympathovagal imbalances in patients with severe obstructive sleep apnea: pilot study using a heart rate variability analysis.
Tae Su Kim, Jun Yeon Won, Eui-Cheol Nam, Yoon-Jong Ryu, Young Ju Jin, Woo Hyun Nam, Ji-Su Jang, Jeong-Whun Kim, Woo Hyun Lee
{"title":"Allergic rhinitis may attenuate the sympathovagal imbalances in patients with severe obstructive sleep apnea: pilot study using a heart rate variability analysis.","authors":"Tae Su Kim, Jun Yeon Won, Eui-Cheol Nam, Yoon-Jong Ryu, Young Ju Jin, Woo Hyun Nam, Ji-Su Jang, Jeong-Whun Kim, Woo Hyun Lee","doi":"10.1007/s11325-024-03203-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The effect of allergic rhinitis (AR) on autonomic nervous system in patients with obstructive sleep apnea (OSA) remains unclear. We utilized heart rate variability (HRV) analysis to assess cardiac autonomic activity in patients with OSA, comparing those with and without allergic rhinitis (AR).</p><p><strong>Methods: </strong>We enrolled 182 patients who visited our sleep clinic complaining of habitual snoring or apnea during sleep. All patients underwent full-night polysomnography (PSG) and multiple allergen simultaneous tests. We calculated the HRV extracted from the electrocardiography of the PSG. Participants were divided into a normal group and an AR group, and HRV indices were compared according to OSA severity in each group.</p><p><strong>Results: </strong>The low-frequency (LF) to high-frequency (HF) ratio (LF/HF; r = 0.336, p < 0.001), LF normalised unit (LFnu; r = 0.345, p < 0.001), and HFnu (r = -0.345, p < 0.001) were significantly correlated with the apnea-hypopnea index. The HRV index comparison between non-severe and severe OSA in the normal group showed significant differences in LFnu (64.7 ± 12.5 in non-severe and 72.4 ± 11.7 in severe, p < 0.001), LF/HF (2.3 ± 1.6 in non-severe and 3.3 ± 2.0 in severe, p = 0.002), and HFnu (35.3 ± 12.5 in non-severe and 27.6 ± 11.7 in severe, p < 0.001). However, in the AR group, LFnu (p = 0.648), LF/HF (p = 0.441), and HFnu (p = 0.648) were comparable between non-severe and severe OSA.</p><p><strong>Conclusion: </strong>Considering that LFnu, HFnu, and LF/HF represent sympathetic activity, parasympathetic activity, and sympathovagal balance, respectively, AR may attenuate the sympathetic predominance and sympathovagal imbalance associated with cardiovascular morbidity in severe OSA.</p>","PeriodicalId":21862,"journal":{"name":"Sleep and Breathing","volume":"29 1","pages":"69"},"PeriodicalIF":2.1000,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sleep and Breathing","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11325-024-03203-0","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: The effect of allergic rhinitis (AR) on autonomic nervous system in patients with obstructive sleep apnea (OSA) remains unclear. We utilized heart rate variability (HRV) analysis to assess cardiac autonomic activity in patients with OSA, comparing those with and without allergic rhinitis (AR).
Methods: We enrolled 182 patients who visited our sleep clinic complaining of habitual snoring or apnea during sleep. All patients underwent full-night polysomnography (PSG) and multiple allergen simultaneous tests. We calculated the HRV extracted from the electrocardiography of the PSG. Participants were divided into a normal group and an AR group, and HRV indices were compared according to OSA severity in each group.
Results: The low-frequency (LF) to high-frequency (HF) ratio (LF/HF; r = 0.336, p < 0.001), LF normalised unit (LFnu; r = 0.345, p < 0.001), and HFnu (r = -0.345, p < 0.001) were significantly correlated with the apnea-hypopnea index. The HRV index comparison between non-severe and severe OSA in the normal group showed significant differences in LFnu (64.7 ± 12.5 in non-severe and 72.4 ± 11.7 in severe, p < 0.001), LF/HF (2.3 ± 1.6 in non-severe and 3.3 ± 2.0 in severe, p = 0.002), and HFnu (35.3 ± 12.5 in non-severe and 27.6 ± 11.7 in severe, p < 0.001). However, in the AR group, LFnu (p = 0.648), LF/HF (p = 0.441), and HFnu (p = 0.648) were comparable between non-severe and severe OSA.
Conclusion: Considering that LFnu, HFnu, and LF/HF represent sympathetic activity, parasympathetic activity, and sympathovagal balance, respectively, AR may attenuate the sympathetic predominance and sympathovagal imbalance associated with cardiovascular morbidity in severe OSA.
期刊介绍:
The journal Sleep and Breathing aims to reflect the state of the art in the international science and practice of sleep medicine. The journal is based on the recognition that management of sleep disorders requires a multi-disciplinary approach and diverse perspectives. The initial focus of Sleep and Breathing is on timely and original studies that collect, intervene, or otherwise inform all clinicians and scientists in medicine, dentistry and oral surgery, otolaryngology, and epidemiology on the management of the upper airway during sleep.
Furthermore, Sleep and Breathing endeavors to bring readers cutting edge information about all evolving aspects of common sleep disorders or disruptions, such as insomnia and shift work. The journal includes not only patient studies, but also studies that emphasize the principles of physiology and pathophysiology or illustrate potentially novel approaches to diagnosis and treatment. In addition, the journal features articles that describe patient-oriented and cost-benefit health outcomes research. Thus, with peer review by an international Editorial Board and prompt English-language publication, Sleep and Breathing provides rapid dissemination of clinical and clinically related scientific information. But it also does more: it is dedicated to making the most important developments in sleep disordered breathing easily accessible to clinicians who are treating sleep apnea by presenting well-chosen, well-written, and highly organized information that is useful for patient care.